Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04154150 · ClinicalTrials.gov registry record · Phase 4
Ketamine + Cognitive Training for Suicidality in the Medical Setting: Pilot
A Phase 4 study, sponsored by Rebecca Price.
- Terminated
- Registry status
- Phase 4
- Development phase
- 16
- Enrollment target
NCT04154150: Clinical Trial Phase 4 study, sponsored by Rebecca Price.
NCT04154150 is a Phase 4 study that was terminated before completion, run by Rebecca Price. The registered enrollment target is 16 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04154150, a Phase 4 study, was terminated before completion, sponsored by Rebecca Price.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 16 participants
- Enrollment target
Study Summary
This project seeks to identify the acute and longer-term impact of a single dose of intravenous ketamine among suicidal patients referred for psychiatric consultation/liaison in the medical inpatient setting. The investigators will then test whether ketamine's rapid effects can be extended by introducing helpful information delivered by a computer-based training protocol. This work could ultimately lead to the ability to treat suicidality more efficiently and with broader dissemination by rapidly priming the brain for helpful forms of learning.
Primary Outcome
depression severity; range 0-60; high score=worse outcome
Interventions
- BEHAVIORAL Sham Training
- BEHAVIORAL Cognitive training
- DRUG Intravenous ketamine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2019-12-19 |
| Est. Completion | 2022-03-15 |
| Phase | Phase 4 |
Why NCT04154150 stopped before completion
NCT04154150 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 3 interventions - of which Sham Training is the first listed.
NCT04154150 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04154150 about?
NCT04154150 is a clinical study titled "Ketamine + Cognitive Training for Suicidality in the Medical Setting: Pilot". This project seeks to identify the acute and longer-term impact of a single dose of intravenous ketamine among suicidal patients referred for psychiatric consultation/liaison in the medical inpatient setting. The investigators will then test whether ketamine's rapid effects can be extended by introd...
What is the current status of trial NCT04154150?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 16 participants. The study started on 2019-12-19. Estimated completion is 2022-03-15.
What interventions are being tested in trial NCT04154150?
The interventions under investigation include: Sham Training (BEHAVIORAL), Cognitive training (BEHAVIORAL), Intravenous ketamine (DRUG).
Who is sponsoring clinical trial NCT04154150?
This trial is sponsored by Rebecca Price, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04154150's enrollment target sits among peer trials
16 1869th of 2000 higher than 121 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI